Variation of fasting serum c-peptide level after admission in japanese patients with type 2 diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 11, Issue 9, 2009, Pages 593-599

  Tajiri, Yuji ^a,b   Kimura, Mikako ^b   Mimura, Kazuo ^b   Umeda, Fumio ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fukuoka Medical Association Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; BIOLOGICAL MARKER; C PEPTIDE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; C PEPTIDE BLOOD LEVEL; CELL FUNCTION; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE DURATION; DISEASE PREDISPOSITION; DRINKING BEHAVIOR; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RELEASE; JAPANESE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATIENT CODING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RETINOPATHY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; AGING; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; DIET, REDUCING; DYSLIPIDEMIAS; EXERCISE; FASTING; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; STATISTICS AS TOPIC;

EID: 70349325999     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0010     Document Type: Article

References (32)

1. Yoshinaga H, Kosaka K: Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 1999;44:129-136.
2. Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y: Factors responsible for development from normal glucose tolerance to isolated postchallenge hyper-glycemia. Diabetes Care 2003;26:1211-1215.
3. Polonsky KS, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, Tager H, Rubenstein AH: Metabolism of C-peptide in the dog: in vivo demonstration of the absence of hepatic extraction. J Clin Invest 1983;72:1114-1123.
4. Polonsky KS, Pugh W, Jaspan JB, Cohen DM, Karrison T, Tager HS, Rubenstein AH: C-peptide and insulin secretion: relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Invest 1984;74:1821-1829.
5. Bratusch-Marrain PR, Waldhausl WK, Gasic S, Hofer A: Hepatic disposal of biosynthetic human insulin and porcine proinsulin in humans. Metabolism 1984;33:151-157.
6. Licinio-Paixao J, Polonsky KS, Given BD, Pugh W, Ostrega D, Frank BF, Rubenstein AH: Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide. J Clin Endocrinol Metab 1986;63:401-403.
7. Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR: Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1990;70:1594-1602.
8. Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kuzuya H, Horwitz DL, Rubenstein AH, Rossing N: Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 1978;62:197-203.
9. Jung CH, Rhee EJ, Kim ER, Kim SY, Shin HS, Lee WY, Oh KW, Park SW, Kim SW: Comparison of the alteration of the concentration of C-peptide in 24-h urine according to the combination patterns of hypoglycemic agents in type 2 diabetes patients. Diabetes Res Clin Pract 2007;77(Suppl): S208-S212.
10. Wasada T, Kuroki H, Arii H, Maruyama A, Katsumori K, Aoki K, Saito S, Omori Y: Hyperglycemia facilitates urinary excretion of C-peptide by increasing glomerular filtration rate in non-insulin-dependent diabetes mellitus. Metabolism 1995;44:1194-1198.
11. Gjessing HJ, Reinholdt B, Faber OK, Pedersen O: The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 1991;124:556-562.
12. Gjessing HJ, Reinholdt B, Pedersen O: The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia. Diabetologia 1989;32: 858-863.
13. Kosaka K, Kuzuya T, Akanuma Y, Hagura R: Increase in insulin response after treatment of overt maturity onset diabetes is independent of the mode of treatment. Diabetolo-gia 1980;18:23-28.
14. Glaser B, Leibovich G, Nesher R, Hartling S, Binder C, Cerasi E: Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol (Copenh) 1988;118:365-373.
15. Clauson P, Alvarsson M, Grill V: Enhancement of B-cell secretion by blood glucose normalisation in type 2 diabetes is associated with fasting C-peptide levels. J Intern Med 1997;241:493-500.
16. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A: Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001;50(Suppl 1):154S-159S.
17. Robertson RP, Olson LK, Zhang HJ: Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 1994;43:1085-1089.
18. Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E: b-Cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 2005;54:2382-2389.
19. Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G: Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997;40:599-605.
20. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002;55:65-85.
21. Ito C, Maeda R, Ishida S, Sasaki H, Harada H: Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 2000;50:225-230.
22. Pfützner A, Löbig M, Fortunato A, Forst T: Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid). Clin Lab 2003;49:227-232.
23. Wajchenberg BL: b-Cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007;28:187-218.
24. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG: The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985; 34:222-234.
25. Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V: Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Diabetes Metab 1996;22:185-191.
26. Ohki Y, Orimo H, Kishi M, Ohkawa T: Indexes of insulin resistance using the oral glucose tolerance test (O-GTT) in Japanese children and adolescents. J Nippon Med School 2004;71:84-87.
27. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA: Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 2008; 31(Suppl 2):S161-S164.
28. Tajiri Y, Mimura K, Umeda F: High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes. Obes Res 2005;13:1810-1816.
29. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY: Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526.
30. Ryan EA, Imes S, Wallace C: Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 2004;27:1028-1032.
31. Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004;27:2597-2602.
32. Monarque-Favard C, Garcia I, Abidi H, Bannier E, Riviere J, Drai J, Bonnefoy M: Malnourished elderly people and lipid status. J Nutr Health Aging 2002;6:370-374.